Europe Bioanalytical Testing Services Market Forecast to 2030

According to The Research Team’ research, the Europe bioanalytical testing services market was valued at US$ 1,374.48 million in 2022 and is expected to reach US$ 2,956.96 million by 2030, registering a CAGR of 10.0% from 2022 to 2030. Increasing outsourcing of R&D activities by pharmaceutical companies and high demand for analytical testing of biosimilars and biologics are among the critical factors attributed to the Europe bioanalytical testing services market expansion.

The research & development, production, and distribution of medicinal drugs and other pharmaceutical products are the major areas of the pharmaceutical industry. Global pharmaceutical consumption is rising with the increasing need for drugs to treat age-related diseases and chronic diseases. According to the WHO, the elderly population aged 60 or above is projected to double from 2020 to 2050, reaching ~2.1 billion by 2050. A rise in the geriatric population would contribute to a surge in incidences of chronic diseases, such as cardiovascular diseases, cancer, hypertension, osteoarthritis, and diabetes mellitus. Thus, chronic diseases have been a major area of focus for pharmaceutical companies. New drug development is a resource-, cost-, and time-intensive process, where later clinical stages result in significant costs. Several pharmaceutical companies are opting for bioanalytical testing services for drug development and validation of assays in both clinical and preclinical stages. Generics and branded drug compounds are mostly small molecules. Generics manufacturers conduct and submit bioanalytical testing results to overcome the issue of patent expiration. Thus, with the uninterrupted proliferation of the pharmaceutical industry, bioanalytical testing service providers are likely to experience a continuous rise in demand for their services in the future, which would lead to new growth opportunity in the bioanalytical testing services market.

On the contrary, challenges in development and validation of bioanalytical methods hurdles the growth of Europe bioanalytical testing services market.

Based on test type, the Europe bioanalytical testing services market is categorized into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held 23.6% market share in 2022, amassing US$ 324.82 million. It is projected to garner US$ 753.30 million by 2030 to expand at 11.1% CAGR during 2022-2030.

Based on disease indication, the Europe bioanalytical testing services market is categorized into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held 22.4% market share in 2022, amassing US$ 307.36 million. It is projected to garner US$ 709.07 million by 2030 to expand at 11.0% CAGR during 2022-2030.

Based on end user, the Europe bioanalytical testing services market is categorized into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held 61.2% share of Europe bioanalytical testing services market in 2022, amassing US$ 840.54 million. It is projected to garner US$ 1,881.01 million by 2030 to expand at 10.6% CAGR during 2022-2030.

Based on country, the Europe bioanalytical testing services market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 26.5% share of Europe bioanalytical testing services market in 2022. It was assessed at US$ 364.26 million in 2022 and is likely to hit US$ 794.27 million by 2030, exhibiting a CAGR of 10.2% during 2022-2030.

Key players operating in the Europe bioanalytical testing services market are SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, KCAS Bioanalytical and Biomarker Services LLC, ICON Plc, and Intertek Group Plc, among others.

In July 2022, Eurofins acquired WESSLING Hungary enhancing its environmental, food and BioPharma product testing offering.

In Jan 2023, Charles River and Rznomics Announced the RNA-based Anticancer Gene Therapy Manufacturing Alliance.

Table 1. Europe Bioanalytical Testing Services Market Segmentation
Table 2. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 3. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 4. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 5. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 6. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 7. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 8. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 9. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 10. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 11. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 12. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 13. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 14. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 15. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 16. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 17. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 18. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 19. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 20. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 21. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 22. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Services
Table 23. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Virology Testing
Table 24. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – Disease Indication
Table 25. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 26. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market
Table 27. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market
Table 28. Glossary of Terms, Europe Bioanalytical Testing Services Market

Figure 1. Europe Bioanalytical Testing Services Market Segmentation, By Country
Figure 2. Europe – PEST Analysis
Figure 3. Europe Bioanalytical Testing Services Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Europe Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
Figure 7. Pharmacokinetics: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Biomarkers: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Immunogenicity: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. In-Vitro Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. In-Vivo Virology Testing: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cell-Based Assays: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 16. Cardiovascular: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Neurological Diseases: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Autoimmune Disorders: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Respiratory Diseases: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Metabolic Disorders: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Oncology: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Sexual Health: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Bone Disease: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
Figure 26. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Contract Research Organization (CRO): Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Others: Bioanalytical Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Europe Bioanalytical Testing Services Market, By Country, 2022 ($Mn)
Figure 31. Europe Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
Figure 32. Germany Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 33. UK Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 34. France Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 35. Italy Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 36. Spain Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 37. Rest of Europe Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
Figure 38. Growth Strategies in the Bioanalytical Testing Services Market